This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pasteran, F. Articles by Procopio, A. Search for Related Content PubMed PubMed Citation Articles by Pasteran, F. Articles by Procopio, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2005, p. 474-475, Vol. 49, No. 1
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.1.474-475.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Novel Variant (bla_VIM-11) of the Metallo-ß-Lactamase bla_VIM Family in a GES-1 Extended-Spectrum-ß-Lactamase-Producing Pseudomonas aeruginosa Clinical Isolate in Argentina

	LETTER

Top Letter References

In November 2002, after 8 days of meropenem treatment (120 mg/kg of body weight/day), P. aeruginosa M5109 was recovered as the sole isolate from the catheter of a 7-month-old patient at the Hospital de Niños "Ricardo Gutierrez." The isolate was confirmed to be P. aeruginosa by using the API20NE system (bioMérieux, Marcy l'Etoile, France) and displayed uncommonly high levels of carbapenem resistance and synergism between imipenem- and zinc chelator-containing disks. Based on the antibiotype profile, colistin was added to the meropenem treatment, and the patient was discharged alive.

By susceptibility analysis carried out by agar dilution according to NCCLS guidelines (6), M5109 showed resistance to ticarcillin (MIC, 1,024 µg/ml), piperacillin (MIC, >1,024 µg/ml), piperacillin-tazobactam (MIC, 512 µg/ml), cefotaxime (MIC, 512 µg/ml), ceftazidime (MIC, 256 µg/ml), cefepime (MIC, 64 µg/ml), aztreonam (MIC, 32 µg/ml), imipenem (MIC, 512 µg/ml), meropenem (MIC, 128 µg/ml), amikacin (MIC, 256 µg/ml), gentamicin (MIC, >512 µg/ml), and ciprofloxacin (MIC, 32 µg/ml) but not to colistin (MIC, 0.5 µg/ml). The addition of 0.4 mM EDTA produced a 32-fold decrease in the carbapenem MICs. A carbapenemase was detected by a microbiological assay (4). Attempts to transfer ceftazidime or imipenem resistance by biparental conjugation (4) to P. aeruginosa ATCC 27853 were unsuccessful.

PCR screening of bla genes followed by DNA sequencing revealed the presence of bla_TEM-1-like (6), bla_OXA-2-like (1), bla_GES-1-like (primers used were GES-F [5'-GAAAAAGCAGCTCAGATCG] and GES-R [5'-CAACAACCCAATCTTTAGGA]), and bla_VIM-2-like (primers used were VIM-F and VIM-R [5]) (amplicons of 500, 480, 580, and 261 bp, respectively). Amplification for other ESBL (bla_CTX-M-2, bla_PER, and bla_SHV [4]) or MBL (bla_SPM-1 and bla_IMP [unpublished data]) genes was negative. Since all the bla_VIM genes and most of the bla_GES genes presently reported are integron located (7, 9), we performed PCRs combining the primer 5'-CS, directed against the 5'-conserved segment of class 1 integrons (4), with either VIM-R or GES-R, rendering amplicons of 475 and 819 bp, respectively. Thus, both bla_VIM-2-like and bla_GES-1-like were found as the first cassettes of different class 1 integrons in M5109. For further sequencing of these genes, additional reverse primers (VIM-Rb [5'-TGTTATGCCGCATCTGCCTG] and GES-Rc [5'-TCAACTATTTGTCCGTGCTC], respectively) were designed based on sequence alignments of highly related genes (Clustal X; ftp://ftp-igbmc.u-strasbg.fr/pub/). The 5'-CS-VIM-Rb amplicon (948 bp) contained an 801-bp-long open reading frame carrying the new bla_VIM-11 allele, which differs from bla_VIM-2 in a unique, nonsynonymous mutation and from bla_VIM-3 or bla_VIM-6 in another nonsilent change. Therefore, it may be considered an evolutionary intermediate between bla_VIM-2 and bla_VIM-3/6 (Fig. 1). The 1,008-bp-long 5'-CS-GES-Rc amplicon harbored an open reading frame of 864 bp that showed a unique silent change (CT) at nucleotide position 591 relative to the bla_GES-1 sequence.

View larger version (17K): [in this window] [in a new window]   FIG. 1. Relatedness of blaVIM genes. (A) Neighbor-joining tree of all the following blaVIM genes reported to date (with GenBank accession numbers given in parentheses): blaVIM-1 (Y18050), blaVIM-2 (AF191564), blaVIM-3 (AF300454), blaVIM-4 (AY135661), blaVIM-5 (AY144612), blaVIM-6 (AY165025), blaVIM-7 (AJ536835), blaVIM-8 (AY524987), blaVIM-9 (AY524988), blaVIM-10 (AY524989), and blaVIM-11 (AY605049). (B) Substitutions in genes highly related to blaVIM-2. The nucleotide positions of the indicated mutations (relative to the blaVIM-2 sequence) are shown. Amino acid changes and their positions based on the numbering system described by Galleni et al. (2) are indicated in parentheses.

This is the first report of an MBL-mediated carbapenem-resistant and ESBL-producing P. aeruginosa isolate in Argentina and the first description anywhere of the coexistence of a VIM variant with GES-1 in a single strain. Our results, together with previous findings (M. Castanheira, R. E. Mendes, T. R. Walsh, A. C. Gales, and R. N. Jones, Letter, Antimicrob. Agents Chemother. 48:2344-2345, 2004; R. E. Mendes et al., letter, 2004), indicate that both VIM- and GES-producing P. aeruginosa strains have already become established in Latin America. The emergence of these enzymes in P. aeruginosa constitutes a public health concern in Argentina which requires efficient detection and brisk intervention to preserve antibiotic options.

	REFERENCES

Top Letter References

 

1. Bert, F., C. Branger, and N. Lambert-Zechovsky. 2002. Identification of PSE and OXA ß-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J. Antimicrob. Chemother. 50:11-18.[Abstract/Free Full Text]
2. Galleni, M., J. Lamotte-Brasseur, G. M. Rossolini, J. Spencer, O. Dideberg, J.-M. Frère, and the Metallo-ß-Lactamase Working Group. 2001. Standard numbering scheme for class B ß-lactamases. Antimicrob. Agents Chemother. 45:660-663.[Free Full Text]
3. Mavroidi, A., E. Tzelepi, A. Tsakris, V. Miriagou, D. Sofianou, and L. S. Tzouvelekis. 2001. An integron-associated ß-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum ß-lactamase IBC-1. J. Antimicrob. Chemother. 48:627-630.[Abstract/Free Full Text]
4. Melano, R., A. Corso, A. Petroni, D. Centrón, B. Orman, A. Pereyra, N. Moreno, and M. Galas. 2003. Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum ß-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina. J. Antimicrob. Chemother. 52:36-42.[Abstract/Free Full Text]
5. Miriagou, V., E. Tzelepi, D. Gianneli, and L. S. Tzouvelekis. 2003. Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-ß-lactamase VIM-1. Antimicrob. Agents Chemother. 47:395-397.[Abstract/Free Full Text]
6. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, 6th ed. Approved standard M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. Nordmann, P., and L. Poirel. 2002. Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect. 8:321-331.[CrossRef][Medline]
8. Toleman, M. A., K. Rolston, R. N. Jones, and T. R. Walsh. 2004. bla_VIM-7, an evolutionarily distinct metallo-ß-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob. Agents Chemother. 48:329-332.[Abstract/Free Full Text]
9. Weldhagen, G. F., L. Poirel, and P. Nordmann. 2003. Ambler class A extended-spectrum ß-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob. Agents Chemother. 47:2385-2392.[Free Full Text]

This article has been cited by other articles:

• Marchiaro, P., Ballerini, V., Spalding, T., Cera, G., Mussi, M. A., Moran-Barrio, J., Vila, A. J., Viale, A. M., Limansky, A. S. (2008). A convenient microbiological assay employing cell-free extracts for the rapid characterization of Gram-negative carbapenemase producers. J Antimicrob Chemother 62: 336-344 [Abstract] [Full Text]  
• Marchiaro, P., Tomatis, P. E., Mussi, M. A., Pasteran, F., Viale, A. M., Limansky, A. S., Vila, A. J. (2008). Biochemical Characterization of Metallo-{beta}-Lactamase VIM-11 from a Pseudomonas aeruginosa Clinical Strain. Antimicrob. Agents Chemother. 52: 2250-2252 [Abstract] [Full Text]  
• Walther-Rasmussen, J., Hoiby, N. (2007). Class A carbapenemases. J Antimicrob Chemother 60: 470-482 [Abstract] [Full Text]  
• Queenan, A. M., Bush, K. (2007). Carbapenemases: the Versatile {beta}-Lactamases. Clin. Microbiol. Rev. 20: 440-458 [Abstract] [Full Text]  
• Pasteran, F., Rapoport, M., Petroni, A., Faccone, D., Corso, A., Galas, M., Vazquez, M., Procopio, A., Tokumoto, M., Cagnoni, V. (2006). Emergence of PER-2 and VEB-1a in Acinetobacter baumannii Strains in the Americas.. Antimicrob. Agents Chemother. 50: 3222-3224 [Full Text]  
• Poirel, L., Naas, T., Nordmann, P. (2006). Pyrosequencing as a Rapid Tool for Identification of GES-Type Extended-Spectrum {beta}-Lactamases.. J. Clin. Microbiol. 44: 3008-3011 [Abstract] [Full Text]  
• Marchiaro, P., Mussi, M. A., Ballerini, V., Pasteran, F., Viale, A. M., Vila, A. J., Limansky, A. S. (2005). Sensitive EDTA-Based Microbiological Assays for Detection of Metallo-{beta}-Lactamases in Nonfermentative Gram-Negative Bacteria. J. Clin. Microbiol. 43: 5648-5652 [Abstract] [Full Text]  

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pasteran, F. Articles by Procopio, A. Search for Related Content PubMed PubMed Citation Articles by Pasteran, F. Articles by Procopio, A.